ANGO vs SHW · rev $292.5M vs P/E 29, rev $23.10B
AngioDynamics Inc (ANGO) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SHW revenue for 2024-12-31 was $23.10B. Net income was $2.68B. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
ANGO currently screens at market cap $378.5M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the ANGO and SHW stock pages for the full models.
Not investment advice.